Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy, Irene Ganan-Gomez, Hui Yang, Feiyang Ma, Guillermo Montalban-Bravo, Natthakan Thongon, Valentina Marchica, Guillaume Richard-Carpentier, Kelly Chien, Ganiraju Manyam, Feng Wang, Ana Alfonso, Shuaitong Chen, Caleb Class, Rashmi Kanagal-Shamanna, Justin P. Ingram, Yamini Ogoti, Ashley Rose, Sanam Loghavi, Pamela Lockyer, Benedetta Cambo, Muharrem Muftuoglu, Sarah Schneider, Vera Adema, Michael McLellan, John Garza, Matteo Marchesini, Nicola Giuliani, Matteo Pellegrini, Jing Wang, Jason Walker, Ziyi Li, Koichi Takahashi, Joel D. Leverson, Carlos Bueso-Ramos, Michael Andreeff, Karen Clise-Dwyer, Guillermo =Garcia-Manero, Simona Colla
Scholarship and Professional Work – COPHS

Hypomethylating Agents Do Not Alter Novel Splicing Events in Myeloid Neoplasms, Hussein Abbas, Feng Wang, Yue Wei, Hui Yang, Guillermo Bravo, Rashmi Kanagal-Shamanna, Caleb Class, Faezeh Darbaniyan, Jianhua Zhang, Andy Futreal, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS